The Mariann and Robert MacDonald Women’s Cancer Risk Evaluation Center is supported by one of the foremost cancer research programs in the country.
Under the leadership of Susan Domchek, MD, Penn's Breast and Ovarian Cancer Risk Evaluation Center has individuals nationally recognized for their expertise. Our Cancer Risk Evaluation Center is backed by our breast cancer research program - one of the few programs of its kind approved and funded by the National Cancer Institute.
Every day, more than 40 Penn scientists and physicians work to increase their knowledge about breast and ovarian cancer and to find new ways to prevent, diagnose and treat this disease. Because of these efforts, research advances can more quickly benefit patients.
As one of the nation's largest cancer research centers, Penn investigators benefit each day from their collaborations and interactions with more than 400 scientists and physicians at the Abramson Cancer Center.